ImpactGuru.com, India’s leading healthcare financing platform for patients, has successfully raised Rs. 16 crore to cover the cost of the World’s Most Expensive Drug, Zolgensma, for Baby Dhairyarajsinh diagnosed with Spinal Muscular Atrophy (SMA) Type 1. Commercially, Zolgensma, a one-time gene replacement therapy, is available in the USA for approximately USD $2.1 million (INR 16 crores). This is the First Fundraiser launched on an Indian crowdfunding platform that raised the entire Rs.16 crore record amount for a SMA Type 1 patient.